Evidence map›Paper›PMID 28729278›Full record

ArticleGenome announcements2017

High-Quality Genome Sequence of the Highly Resistant Bacterium

Farideh Hosseinkhani, Mohammad Emaneini, Willem van Leeuwen

Open access · diamondAbstract read
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Farideh HosseinkhaniDepartment of Innovative Molecular Diagnostics, University of Applied Sciences Leiden, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-1880-6964
Mohammad EmaneiniDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Willem van LeeuwenDepartment of Innovative Molecular Diagnostics, University of Applied Sciences Leiden, Leiden, The Netherlands leeuwen.van.w@hsleiden.nl.
University of Applied Sciences Leiden · NLTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using Illumina HiSeq and PacBio technologies, we sequenced the genome of the multidrug-resistant bacterium

Identifiers

PMID28729278
PMCPMC5522945
OpenAlexW2737843090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.